246 related articles for article (PubMed ID: 3746133)
21. Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway.
Crawford SE; Borensztajn J
J Lipid Res; 1999 May; 40(5):797-805. PubMed ID: 10224148
[TBL] [Abstract][Full Text] [Related]
22. Clearance of lipoprotein remnant particles in adipose tissue and muscle in humans.
Karpe F; Humphreys SM; Samra JS; Summers LK; Frayn KN
J Lipid Res; 1997 Nov; 38(11):2335-43. PubMed ID: 9392431
[TBL] [Abstract][Full Text] [Related]
23. Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester.
van Bennekum AM; Kako Y; Weinstock PH; Harrison EH; Deckelbaum RJ; Goldberg IJ; Blaner WS
J Lipid Res; 1999 Mar; 40(3):565-74. PubMed ID: 10064745
[TBL] [Abstract][Full Text] [Related]
24. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
25. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver.
Shafi S; Brady SE; Bensadoun A; Havel RJ
J Lipid Res; 1994 Apr; 35(4):709-20. PubMed ID: 8006526
[TBL] [Abstract][Full Text] [Related]
26. Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E.
Brasaemle DL; Cornely-Moss K; Bensadoun A
J Lipid Res; 1993 Mar; 34(3):455-65. PubMed ID: 8468529
[TBL] [Abstract][Full Text] [Related]
27. Plasma very low density lipoprotein (VLDL) in cholesterol-fed rabbits: chylomicron remnants or liver lipoproteins?
Thompson KH; Zilversmit DB
J Nutr; 1983 Oct; 113(10):2002-10. PubMed ID: 6619979
[TBL] [Abstract][Full Text] [Related]
28. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway.
Hussain MM; Innerarity TL; Brecht WJ; Mahley RW
J Biol Chem; 1995 Apr; 270(15):8578-87. PubMed ID: 7721759
[TBL] [Abstract][Full Text] [Related]
29. The metabolic impact of oral contraceptives.
Krauss RM; Burkman RT
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
[TBL] [Abstract][Full Text] [Related]
30. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor.
Kita T; Goldstein JL; Brown MS; Watanabe Y; Hornick CA; Havel RJ
Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3623-7. PubMed ID: 6285353
[TBL] [Abstract][Full Text] [Related]
31. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.
Choi SY; Fong LG; Kirven MJ; Cooper AD
J Clin Invest; 1991 Oct; 88(4):1173-81. PubMed ID: 1918372
[TBL] [Abstract][Full Text] [Related]
32. Delayed clearance of postprandial chylomicrons and their remnants in the hypoalphalipoproteinemia and mild hypertriglyceridemia syndrome.
Ooi TC; Simo IE; Yakichuk JA
Arterioscler Thromb; 1992 Oct; 12(10):1184-90. PubMed ID: 1390590
[TBL] [Abstract][Full Text] [Related]
33. Chinese hamster ovary cells expressing a cell surface-anchored form of hepatic lipase. Characterization of low density lipoprotein and chylomicron remnant uptake and selective uptake of high density lipoprotein-cholesteryl ester.
Komaromy M; Azhar S; Cooper AD
J Biol Chem; 1996 Jul; 271(28):16906-14. PubMed ID: 8663289
[TBL] [Abstract][Full Text] [Related]
34. Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.
Wilson DE; Chan IF; Buchi KN; Horton SC
Metabolism; 1985 Jun; 34(6):551-8. PubMed ID: 3999977
[TBL] [Abstract][Full Text] [Related]
35. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
[TBL] [Abstract][Full Text] [Related]
36. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype.
Brenninkmeijer BJ; Stuyt PM; Demacker PN; Stalenhoef AF; van 't Laar A
J Lipid Res; 1987 Apr; 28(4):361-70. PubMed ID: 3585171
[TBL] [Abstract][Full Text] [Related]
37. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
38. Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake.
Hussain MM; Mahley RW; Boyles JK; Fainaru M; Brecht WJ; Lindquist PA
J Biol Chem; 1989 Jun; 264(16):9571-82. PubMed ID: 2722852
[TBL] [Abstract][Full Text] [Related]
39. Infusion of atherogenic lipoprotein particles increases hepatic lipase activity in the rabbit.
Ebert DL; Warren RJ; Barter PJ; Mitchell A
J Lipid Res; 1993 Jan; 34(1):89-94. PubMed ID: 8445346
[TBL] [Abstract][Full Text] [Related]
40. The uptake of chylomicron remnants and very low density lipoprotein remnants by the perfused rat liver.
Arbeeny CM; Rifici VA
J Biol Chem; 1984 Aug; 259(15):9662-6. PubMed ID: 6086643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
